A Pilot, Randomized, Open-label Study in Patients on Chronic Dialysis With End Stage Renal Disease (Esrd), to Evaluate the Enhancing Effect of Two Doses of Thymosin Alpha 1 on the Immunogenicity of h1n1sw Monovalent Vaccine.
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Thymalfasin (Primary) ; Influenza A virus vaccine-H1N1; MF 59
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- 17 Mar 2012 Actual end date changed from 18 May 2010 to 4 Nov 2010 as reported by EudraCT.
- 14 Dec 2011 Results published in Vaccine.
- 14 Dec 2011 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History